Q1 2026 Rallis India Ltd Earnings Call Transcript
Key Points
- Rallis India Ltd (BOM:500355) reported a robust Q1 performance with revenue increasing by 20% to INR967 crores and profit after tax doubling to INR95 crores compared to the previous year.
- The Crop Care and seed businesses showed strong performance, with growth rates of 16% and 38% respectively over the previous year.
- The company launched nine new products in the Crop Protection business, including herbicides, fungicides, and insecticides, aligning with their strategy to strengthen the herbicide portfolio.
- Rallis India Ltd (BOM:500355) is focusing on digital and artificial intelligence initiatives to enhance customer engagement and operational efficiency.
- The export business saw a significant increase, with revenues up by 75% compared to the same period last year, driven by growth in key products like metribuzin and hexaconazole.
- The global agrochemical market is recovering slowly, with regions like Latin America, APAC, and Africa stabilizing at a gradual pace.
- Challenges persist in the CSM business due to phasing issues, although it is on track for the full year.
- Acephate continues to face challenges in key markets like Brazil and the US, impacting its performance.
- There are concerns about illegal RRBT cotton affecting the cotton segment, despite better price realization.
- The company faces supply constraints in maize and paddy, which have impacted the seed business.
Ladies and gentlemen, good morning, and welcome to the Rallis India Limited Q1 FY26 Earnings Conference Call. (Operator Instructions)
Please note that this conference is being recorded. Ladies and gentlemen, we have with us today, Dr. Gyanendra Shukla, Managing Director and CEO; and Ms. Subhra Gourisaria, Chief Financial Officer. Before we begin, I'd like to mention that some of the statements made in today's discussions may be forward-looking in nature and may involve risks and uncertainties.
A detailed statement in this regard is available in the results presentation. I now invite Dr. Gyanendra Shukla to begin the proceedings of the call. Thank you, and over to you, sir.
Just wanted to check if people can hear us.
Yes, sir please go ahead.
Okay. Great.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
